Leadership Overview
EXALTA has 4 executives leading key functions including financial strategy, technological innovation, human capital management, and corporate governance.
Driven by a commitment to clinical excellence, EXALTA advances medical technology through the integration of specialized manufacturing expertise to improve patient outcomes across the global healthcare landscape.
Driven by a commitment to clinical excellence, EXALTA advances medical technology through the integration of specialized manufacturing expertise to improve patient outcomes across the global healthcare landscape.
Leadership Roles at EXALTA
Damien Sibilla - Chief Financial Officer
Damien Sibilla, the Chief Financial Officer at EXALTA, directs all fiscal operations and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures alignment between budgetary resources and the manufacturing requirements of the medical device portfolio. This leadership role involves managing complex financial reporting, optimizing cost structures across the supply chain, and supporting the integration of the three founding entities. By maintaining rigorous fiscal discipline, Damien Sibilla directly impacts the long-term sustainability of the company. Sibilla secures the necessary capital to fund research and development initiatives, thereby enabling the production of innovative surgical solutions. Through precise financial planning, the Chief Financial Officer facilitates the expansion of market reach across North American and international healthcare sectors, ensuring that the business maintains a competitive edge in the medical technology industry while delivering consistent value to stakeholders and healthcare providers.
Jeffrey Tyber - Group President and Board Member
Jeffrey Tyber, the Group President and Board Member at EXALTA, directs the overarching strategic vision and corporate governance of the organization. Overseeing the alignment of business units with the long-term mission, the Group President and Board Member ensures that the company remains focused on advancing clinical outcomes through innovative medical devices. This leadership role involves collaborating with the Board to define market expansion strategies and operational priorities. By leveraging deep industry expertise, Jeffrey Tyber directly impacts the strategic trajectory of the company following the merger of the three founding pioneers. Tyber manages high-level stakeholder relationships and ensures that the organization adheres to the highest standards of corporate responsibility. Through the execution of growth-oriented initiatives, the Group President and Board Member drives the company's presence in the global healthcare market. This leadership ensures that the business continues to provide comprehensive, high-quality solutions that enhance surgical procedures and improve patient care across the medical device manufacturing sector.
David Hannah - Chief Technology Officer
David Hannah, the Chief Technology Officer at EXALTA, architects the technical roadmap for all medical device development and manufacturing processes. Overseeing the engineering teams, the Chief Technology Officer drives the creation of advanced surgical tools that improve clinical outcomes. This leadership role involves integrating the diverse technological portfolios of the founding organizations into a unified, high-performance product suite. By fostering a culture of innovation, David Hannah directly impacts the company's ability to meet the evolving needs of surgeons and patients. Hannah manages the transition from conceptual design to large-scale manufacturing, ensuring that every product meets stringent regulatory standards. Through the implementation of cutting-edge manufacturing technologies, the Chief Technology Officer optimizes production efficiency and product quality. This strategic focus on technical advancement allows the company to maintain a leading position in the medical device sector, providing healthcare providers with reliable, state-of-the-art solutions for complex medical treatments.
DenaRae Walter - Chief People Officer
DenaRae Walter, the Chief People Officer at EXALTA, directs all human capital strategies and organizational development initiatives. Overseeing the recruitment, retention, and professional growth of the workforce, the Chief People Officer ensures that the company attracts top-tier talent capable of advancing medical technology. This leadership role involves harmonizing the corporate cultures of the three merged entities into a cohesive, high-performing team. By implementing robust talent management programs, DenaRae Walter directly impacts the operational efficiency and innovation capacity of the organization. Walter fosters an inclusive environment that supports the diverse needs of employees across all manufacturing and administrative functions. Through the development of comprehensive training and leadership programs, the Chief People Officer prepares the workforce to meet the challenges of the competitive MedTech market. This focus on human capital ensures that the company maintains the expertise required to deliver superior medical devices and solutions to healthcare providers globally.
Explore Leadership Teams in Manufacturing
B. Braun Melsungen AG is a German multinational medical devices and pharmaceutical company headquartered in Melsungen, Hesse. Founded in 1839, the company develops, manufactures, and markets a broad range of medical products and services including infusion therapy, surgical instruments, wound care, dialysis, and hospital pharmacy solutions. B. Braun operates in over 60 countries worldwide.
Company Leadership SF
YR
SS
MA
Miracle-Ear, a division of Amplifon Group, has been a trusted resource in hearing solutions for over 70 years. Based in Minneapolis, MN, Miracle-Ear specializes in customizable hearing solutions that feature discreet, comfortable products designed to meet each individual's hearing loss needs.
Company Leadership JC
AS
PK
Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.
Company Leadership
ND


Elcam Medical is a leading manufacturer of disposable medical devices and components tailored for the OEM market, specializing in innovative flow control solutions. Their product range includes stopcocks, manifolds, and various accessories designed for critical medical applications such as Intensive Care, Anesthesia, Dialysis, and Interventional Cardiology. The company focuses on providing customized solutions that enhance safety and efficiency in medical procedures. Elcam Medical partners with top industry players to ensure high-quality standards and effective fluid management in healthcare.
Company Leadership DD
MG
ID
IK